Listen Now

In this episode of the Life Science Success podcast my guest is Robert Bruchet.  Robert is a General Manager - Middle East & Africa at Ethypharm. He applies a deep understanding of commercial levers to maximize the P&L and drive growth. Demonstrated leadership across multiple functions (marketing, sales, market access, and public affairs) and general management. Rob Bruchet discusses his work in the pharmaceutical industry in Africa and the Middle East He talks about the challenges of expanding a business in that region, particularly with established brands and price pressure Bruchet emphasizes the importance of diversity in those markets, noting the wide range of languages and cultures He also shares his experience working in Dubai and the sense of adventure that drove him to move there Bruchet enjoys the opportunity to create something new and make changes in his work, and he is motivated by the drive and ambition of younger people in the industry

The interview discusses challenges faced by at-home diagnostic companies, including differentiation from competitors, market education, and lack of direct billing code. Opportunities for growth in the at-home healthcare market are highlighted, while concerns include the blurring of personal and work life and potential for overcommitment. Exciting developments in technology, particularly in digital health and medtech, are noted as improving quality of life for individuals. Challenges faced include differentiating from competitors, educating the market, and lack of direct billing code for at-home diagnostics Opportunities include growth as at-home healthcare becomes more mainstream Concerns include the blurring of the line between personal and work life and the potential for overcommitment Exciting developments in technology, particularly in the digital health and medtech fields, improving quality of life for individuals

In this episode of the Life Science Success Podcast my guest is Chris Anderson.  Chris is a seasoned Pharmaceutical Professional with more than 20 years of experience in multiple fields within the Industry.   Don Davis and Chris Anderson discuss the regenerative medicine industry Chris highlights the need for partnerships between companies and government entities The challenges of ensuring compliance and patient safety in a new and evolving industry are discussed Chris talks about being inspired by the people and ideas in the industry They both express excitement about the potential for future advancements in regenerative medicine and other areas like AI.

In this episode of the Life Science Success podcast, my guest is Dr. Scott Wagers.  Scott is the CEO of BioSci Consulting, the author of Assembled Chaos, and the host of Beyond Publications podcast. (Consortium Whisperer)   Dr. Scott Wagers helps people develop consortium projects to speed up the realization of the future of medicine. The translational gap is the delay between research findings and clinical implementation, and it takes about 17 years to cross. The bottleneck in the translational gap is the resistance to change and the lack of adoption. AI has the potential to free humans to focus on what they're really optimized for, which is creativity, pattern recognition, and working together. The human mind is optimized for certain things that AI can free us to focus on. Collective thinking of a bunch of different people is a very powerful computer in its own right. Leadership isn't just at the very top level; it's at every level, down to the PhD student who writes an outline or an SOP. Beyond Publications is a podcast about going beyond publications and pushing through the translational gap. Patients inspire Dr. Scott Wagers, and the translational gap concerns him. The dynamic of collective thinking and working together excites Dr. Scott Wagers.  

This week on the Life Science Success Podcast my guest is Nathan Clark.  Nathan is the co-founder of Ganymede and is passionate about biotechnology. He is at the frontier of biology and engineering, and has merged his profound knowledge in this field with business development to reimagine data infrastructure in the life sciences.   Nathan Clark discusses his company's goal to become the infrastructure for the life sciences industry The industry is moving slowly in terms of digital transformation and data integration The complexity of data in the life sciences industry is a unique problem that requires a science of managing that complexity Instrument manufacturers are inhibiting connectivity by putting all their data into different formats The goal is to create a centralized data lake that can be mapped together and linked The complexity of the industry and the slow pace of digital transformation concerns Nathan Clark Nathan Clark is excited about the potential for scientific advancements in the life sciences industry, including understanding epigenetics and how biological systems interact with each other  

The Happy Engineer 🎧 Top Podcast Host || Helping Thousands of Engineering Leaders Reach the Next Level (without Suffering Burnout) || World's Best Lifestyle Engineer || CEO & Career Coach    In this episode of Life Science Success, my guest is Zach White.   Zach is the host of the Happy Engineer Podcast, and he is also a career coach who is helping thousands of engineering leaders reach the next level without suffering burnout.    Zach White discusses the challenges that engineers face in their careers, including continually increasing demands and the need to balance leadership development with technical knowledge. He also discusses the importance of mindset and coaching to help engineers achieve their goals and find fulfillment in their work. Zach is inspired by seeing clients take courageous steps and achieve what they previously thought was impossible. He is concerned about the impact of financial systems and policies on the economy and the need for continual learning in the face of rapidly advancing technology. Zach is excited about travel and the opportunity to experience new places and cultures. The Happy Engineer Podcast, hosted by Zach, focuses on helping engineers build their careers, balance their lives, and find happiness along the way.

In this episode of Life Science Success, my guest is Gino Martini.  Gino is the CEO of the Precision Health Technologies Accelerator (PHTA Ltd).  Previously, he was the Chief Scientist of the Royal Pharmaceutical Society.    Key Topics Covered:    Description of an accelerator program for health tech companies The importance of social interaction for innovation in a hybrid work environment Excitement for precision medicine and personalized treatment plans Interest in bedside manufacturing and its potential for patient care Challenges in the life sciences industry, such as the lack of lab space and access to skills Opportunities in precision medicine, bedside manufacturing, and the microbiome  

AJ Melet is the CEO of a startup biotechnology company Ronawk Inc. Ronawk Inc’s technology involves growing cells in a tissue mimetic substrate called bio blocks. The cells grow in 3D and form their own micro tissues, which can be used to manufacture new therapies. Roanoke's technology has potential applications in tissue engineering and scaling the production of biological factors. The biggest challenges Roanoke is currently facing are building a new lab and getting people to understand the new technology. AJ Melet is inspired by people who serve others, concerned about our ability to connect in a digital world, and excited by people tackling big challenges.

In this episode of Life Science Success, my guest is Katherine Vega Stultz.  Katherine is the President and CEO of Ocelot Bio, a clinical stage company focused on developing innovative therapeutics to significantly improve outcomes for patients with end-stage liver disease.   In this episode of Life Science Success my guest is Katherine Vega Stultz and we touch upon a number of topics, including the non-linear path of career growth, the importance of being a generalist in a specialized industry, and the challenges and opportunities facing Ocelot Bio, a private venture-backed company that is focused on liver disease. Stultz talks about the importance of team collaboration, transparency, and communication, and how her experiences have helped her develop a continuous improvement mindset. She also discusses her passion for tackling complex problems that impact people's lives and how she is excited to be in a position of leadership that advocates for diversity and talent. Non-linear path of career growth Importance of being a generalist in a specialized industry Challenges and opportunities facing Ocelot Bio Importance of team collaboration, transparency, and communication Continuous improvement mindset Passion for tackling complex problems that impact people's lives Advocacy for diversity and talent in leadership

In this episode of the Life Science Success podcast, my guest is Martin-Immanuel Bittner 𝘔𝘋 𝘋𝘗𝘩𝘪𝘭 𝘍𝘙𝘚𝘈. Martin-Immanuel is the CEO & Co-Founder of Arctoris, a biotech platform company powered by robotics and machine learning based in Oxford and Boston.   Martin-Immanuel Bittner is the CEO and founder of Arctoris, a biotech platform company focused on drug discovery with partnerships worldwide.  Martin-Immanuel Bittner is the CEO and founder of Arctoris, a biotech platform company powered by robotics and machine learning based in Oxford and Boston The company's focus is on drug discovery, and it has partnerships with dozens of biotech and pharma companies worldwide The company is actively hiring and anticipates continued revenue growth and team growth in the coming years Bittner is excited about the continued drive towards having physiologically more relevant model systems Bittner sees AI and machine learning as powerful tools that will be increasingly adopted in a drug discovery context and predicts that all drugs reaching the market will have had some form of AI involvement in the future Bittner is concerned about human health being jeopardized by conflicts between different geopolitical blocks and the risk management that companies need to consider Bittner is excited about the transformation of the industry and the opportunities that lie ahead with new technologies and techniques that can bring more and better drugs to patients faster

In this episode of the Life Science Success podcast, my guest is Bremer Louw.  Bremer is the vice president of operations at Bioforum, a data focused CRO. He has been in the clinical research industry for over 15 years and has extensive experience in data management and biostatistics programming.   Bremer Louw, VP of Operations at Bioform, discusses the company's focus on meeting customer needs and building solutions for complex problems. He also expresses concerns about the pace of innovation and the ethical and regulatory implications of machine learning and artificial intelligence in the life sciences industry. Louw emphasizes the importance of small successes and momentum in achieving larger goals. Bioform is a smaller, more nimble organization with a different culture than larger companies like IQVIA. Bioform is attentive to customers' needs and works to meet them on an individual basis. Bremer Louw, the VP of Operations at Bioform, is responsible for overseeing operational metrics, professional services, quality, business development, and innovation. Bioform works with both drug and diagnostic companies. Louw is concerned about the pace of innovation in the industry and the ethical and regulatory implications of machine learning and artificial intelligence. Louw emphasizes the importance of small successes and momentum in achieving larger goals.

In this episode of Life Science Success my guest is Siddhartha Shrivastava, Ph.D.  Sidd is the  Vice President, Head of CMC and Global Technical Operations at Cue Biopharma.  He is a proven leader and well-published scientific-technical operations professional with experience in leading research, early to late-stage process development, commercial launch, cGMP commercial manufacturing (DS/DP), due diligence of new targets and facility acquisition, end to end supply chain management, and CMO management for bio-therapeutic drugs.

In this episode of the Life Science Success Podcast my guest is Vadim Klyushnichenko, Ph.D,   Vadim is the VP Pharmaceutical Development at Scripps Research.  He has over 25 years of progressive experience in Global Bio/Pharmaceutical Development from Discovery to Clinical and Commercial Manufacturing.

In this episode of Life Science Success, my guest is Dr. Steven Fox.  Dr Fox is an experienced entrepreneur, doctor, educator and author.  He is also the founder and chairman of Akelos Inc. a biotechnology company developing non-addictive, non-opioid drugs for the treatment of neuropathic chronic pain.

This week on the Life Science Success Podcast my guest is Jae Yoo.  Jae is the Executive Director at EPM Scientific.  EPM Scientific exists to enable exceptional careers around the world. They connect exceptional talent, with exceptional opportunities.

This week on the Life Science Success Podcast my guest is Cristina Varner.  Cristina is the National Life Science and Digital Health & Telemedicine Practice Leader for Newfront.  She supports the risk management needs of biotech, medical device, pharmaceutical, diagnostic, digital health and telemedicine companies from early stage on up.

This week on the Life Science Success Podcast, my guest is Stefan Lukianov.  Stefan is the Founder/CEO of Salve Therapeutics, a biotech company in LA building viral biologics with computational tools. 

In this interview for Life Science Success, my guest is Elizabeth Smalley.  Elizabeth is the Sr. Product Manager at ArisGlobal.  With over 15 years of experience across data analytics, Elizabeth has a passion for exploring the intersection of data science and human reasoning, and has experience bringing AI-powered software to market, to drive safety and clinical outcomes for patients and clinicians.

In this interview of Life Science Success my guest is Andrew Norris.  Andrew is the co-founder of BCN Biosciences, a recent startup that has projects ongoing in the oncology drug space.

In this episode of Life Science Success, my guest is Amy Brown.  Amy is an executive with 20 years of public and private sector experience in health care public relations, startup management, policy development, quality improvement, and insurance operations.  She is also the founder and CEO of AuthentiCx.